Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Androgen | 7 | 2012 | 31 | 1.440 |
Why?
|
| Lectins, C-Type | 2 | 2024 | 90 | 0.840 |
Why?
|
| Necrosis | 1 | 2019 | 144 | 0.620 |
Why?
|
| Receptors, Cell Surface | 1 | 2019 | 431 | 0.540 |
Why?
|
| Mice, Knockout | 9 | 2024 | 2109 | 0.510 |
Why?
|
| Histones | 1 | 2019 | 481 | 0.510 |
Why?
|
| Liver | 2 | 2019 | 847 | 0.480 |
Why?
|
| Hirsutism | 1 | 2012 | 2 | 0.400 |
Why?
|
| Alopecia | 1 | 2012 | 25 | 0.390 |
Why?
|
| Acne Vulgaris | 1 | 2012 | 24 | 0.390 |
Why?
|
| Adaptive Immunity | 2 | 2012 | 101 | 0.390 |
Why?
|
| Uric Acid | 1 | 2012 | 47 | 0.390 |
Why?
|
| Androgens | 1 | 2012 | 48 | 0.390 |
Why?
|
| Gout | 1 | 2012 | 48 | 0.380 |
Why?
|
| Wound Healing | 2 | 2012 | 189 | 0.380 |
Why?
|
| Macrophages | 2 | 2019 | 1039 | 0.320 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2009 | 613 | 0.310 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2009 | 112 | 0.310 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 129 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 3394 | 0.300 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 212 | 0.270 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 536 | 0.270 |
Why?
|
| Immunity, Innate | 2 | 2012 | 796 | 0.270 |
Why?
|
| Hypertension | 1 | 2012 | 583 | 0.270 |
Why?
|
| Skin | 1 | 2009 | 377 | 0.260 |
Why?
|
| Mice | 10 | 2024 | 10839 | 0.250 |
Why?
|
| Cell Differentiation | 2 | 2009 | 1351 | 0.230 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 833 | 0.230 |
Why?
|
| Peritonitis | 1 | 2024 | 36 | 0.220 |
Why?
|
| Inflammation | 3 | 2024 | 1143 | 0.210 |
Why?
|
| Animals | 11 | 2024 | 20646 | 0.190 |
Why?
|
| Apoptosis | 3 | 2019 | 1073 | 0.180 |
Why?
|
| Sepsis | 1 | 2024 | 279 | 0.170 |
Why?
|
| Jurkat Cells | 1 | 2019 | 110 | 0.160 |
Why?
|
| Endosomes | 1 | 2019 | 178 | 0.150 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2019 | 211 | 0.150 |
Why?
|
| Lymphocyte Activation | 3 | 2012 | 759 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2019 | 617 | 0.140 |
Why?
|
| T-Lymphocytes | 2 | 2012 | 1007 | 0.140 |
Why?
|
| Neutrophils | 1 | 2019 | 376 | 0.130 |
Why?
|
| Curcumin | 3 | 2012 | 80 | 0.110 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2009 | 3 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 139 | 0.100 |
Why?
|
| Androgen Antagonists | 1 | 2012 | 22 | 0.100 |
Why?
|
| Crystallization | 1 | 2012 | 99 | 0.100 |
Why?
|
| Models, Immunological | 1 | 2012 | 85 | 0.100 |
Why?
|
| Testosterone | 2 | 2009 | 121 | 0.090 |
Why?
|
| Interleukin-1 | 1 | 2012 | 153 | 0.090 |
Why?
|
| Thymus Gland | 1 | 2012 | 233 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 130 | 0.090 |
Why?
|
| Immune System Diseases | 1 | 2011 | 17 | 0.090 |
Why?
|
| Antigens | 1 | 2011 | 147 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2012 | 390 | 0.080 |
Why?
|
| Administration, Topical | 1 | 2009 | 51 | 0.080 |
Why?
|
| Interferon-gamma | 2 | 2009 | 568 | 0.080 |
Why?
|
| Th2 Cells | 1 | 2009 | 98 | 0.080 |
Why?
|
| Comorbidity | 1 | 2012 | 1117 | 0.080 |
Why?
|
| Neutropenia | 1 | 2009 | 67 | 0.080 |
Why?
|
| Interleukin-17 | 1 | 2009 | 94 | 0.080 |
Why?
|
| Humans | 7 | 2019 | 62934 | 0.080 |
Why?
|
| Th1 Cells | 1 | 2009 | 175 | 0.080 |
Why?
|
| Immunity | 1 | 2009 | 107 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2011 | 524 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2009 | 203 | 0.070 |
Why?
|
| Bacterial Infections | 1 | 2009 | 148 | 0.070 |
Why?
|
| Inflammasomes | 1 | 2011 | 334 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 894 | 0.070 |
Why?
|
| Autoimmunity | 1 | 2009 | 238 | 0.070 |
Why?
|
| Biomarkers | 1 | 2012 | 1387 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2008 | 178 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 570 | 0.060 |
Why?
|
| Cytokines | 1 | 2009 | 934 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2008 | 297 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2012 | 3027 | 0.060 |
Why?
|
| Models, Biological | 1 | 2009 | 1182 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2024 | 320 | 0.050 |
Why?
|
| Male | 6 | 2024 | 29594 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2004 | 164 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 644 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 669 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 641 | 0.040 |
Why?
|
| Female | 5 | 2012 | 32587 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 2188 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2012 | 983 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2012 | 2156 | 0.030 |
Why?
|
| Aged | 1 | 2009 | 14278 | 0.030 |
Why?
|
| Thymocytes | 1 | 2012 | 21 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 72 | 0.030 |
Why?
|
| Organ Size | 1 | 2012 | 172 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2009 | 908 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 238 | 0.020 |
Why?
|
| Proteolysis | 1 | 2012 | 145 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2011 | 35 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2012 | 287 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 573 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 284 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2011 | 263 | 0.020 |
Why?
|
| Granulocytes | 1 | 2009 | 71 | 0.020 |
Why?
|
| Arthritis, Experimental | 1 | 2009 | 29 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2009 | 57 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2009 | 77 | 0.020 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2009 | 46 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 293 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 149 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 302 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2008 | 34 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2008 | 52 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 273 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2008 | 224 | 0.020 |
Why?
|
| DNA Repair | 1 | 2008 | 246 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2008 | 295 | 0.020 |
Why?
|
| Homeostasis | 1 | 2009 | 369 | 0.020 |
Why?
|
| DNA Damage | 1 | 2008 | 284 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 877 | 0.010 |
Why?
|
| Phenotype | 1 | 2009 | 1196 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 12 | 0.010 |
Why?
|
| Immunotoxins | 1 | 2004 | 7 | 0.010 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 7 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 2004 | 39 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 63 | 0.010 |
Why?
|
| CD3 Complex | 1 | 2004 | 65 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2004 | 71 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2004 | 46 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2004 | 167 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 149 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2004 | 150 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 373 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 217 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 451 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 495 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 863 | 0.010 |
Why?
|
| Adult | 1 | 2004 | 16664 | 0.000 |
Why?
|